Iodine-124 clinical trials
Also written Iodine-124.
How each study uses Iodine-124 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Iodine-124 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- Iodine-124
- 3
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2018 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Memorial Sloan Kettering Cancer Center (1) · Thomas Hope (1) · Stanford University (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Iodine-124.
- Aug 2027Lesion Dosimetry With Iodine-124 in Metastatic Thyroid CarcinomaPhase 1 · Memorial Sloan Kettering Cancer Center
Studies
Open first, then newest update. How each study uses Iodine-124 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Lesion Dosimetry With Iodine-124 in Metastatic Thyroid CarcinomaRecruitingPhase 1Memorial Sloan Kettering Cancer CenterNCT03647358Written as Iodine-124
- Comparison of I-124 PET/CT for the Diagnosis of Thyroid CancerRecruitingPhase 2Thomas HopeNCT06961084Written as Iodine-124
- Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CTTerminatedEarly Phase 1Stanford UniversityNCT00725946Written as Iodine-124
Codes
What other systems call Iodine-124 · ClinicalTrials.gg INT000619
- MeSH (NLM) C000614959Iodine-124One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000614959 | Iodine-124 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.